Effect of serine and tyrosine phosphorylation on retroviral proteinase substrates.
暂无分享,去创建一个
J. Louis | T. Copeland | E. Majerová | J. Tözsér | P. Bagossi | P. Boross | J M Louis | J Tözsér | P Bagossi | P Boross | E Majerova | S Oroszlan | T D Copeland | S. Oroszlan
[1] A Wlodawer,et al. Analysis of substrate interactions of the Rous sarcoma virus wild type and mutant proteases and human immunodeficiency virus-1 protease using a set of systematically altered peptide substrates. , 1992, The Journal of biological chemistry.
[2] V. Vogt,et al. Primary structure of p19 species of avian sarcoma and leukemia viruses , 1985, Journal of virology.
[3] J. Mellors. Closing in on human immunodeficiency virus–1 , 1996, Nature Medicine.
[4] S. Oroszlan,et al. The preparation and biochemical characterization of intact capsids of equine infectious anemia virus. , 1989, Biochemical and biophysical research communications.
[5] A. Tomasselli,et al. Specificity of retroviral proteases: an analysis of viral and nonviral protein substrates. , 1994, Methods in enzymology.
[6] D. Grandgenett,et al. Phosphorylation of the avian retrovirus integration protein and proteolytic processing of its carboxyl terminus , 1991, Journal of virology.
[7] Wen-Chuan Lee,et al. Autophosphorylation-dependent protein kinase phosphorylates Ser25, Ser38, Ser65, Ser71, and Ser411 in vimentin and thereby inhibits cytoskeletal intermediate filament assembly , 1994, Journal of protein chemistry.
[8] A. Wlodawer,et al. Structure-based inhibitors of HIV-1 protease. , 1993, Annual review of biochemistry.
[9] M. Inagaki,et al. Domain- and sequence-specific phosphorylation of vimentin induces disassembly of the filament structure. , 1989, Biochemistry.
[10] A Wlodawer,et al. Mutations that alter the activity of the Rous sarcoma virus protease. , 1992, The Journal of biological chemistry.
[11] P. Traub,et al. Proteolysis of vimentin and desmin by the Ca2+-activated proteinase specific for these intermediate filament proteins , 1983, Molecular and cellular biology.
[12] D. Grandgenett,et al. Structural characterization of the avian retrovirus reverse transcriptase and endonuclease domains. , 1985, The Journal of biological chemistry.
[13] N. Nakamura,et al. Purification and characterization of a vimentin-specific protease in mouse myeloid leukemia cells. Regulation during differentiation and identity with cathepsin G. , 1992, European journal of biochemistry.
[14] A. Skalka,et al. Proteolytic processing of avian sarcoma and leukosis viruses pol-endo recombinant proteins reveals another pol gene domain , 1987, Journal of virology.
[15] T. Smithgall,et al. Phosphorylation-dependent human immunodeficiency virus type 1 infection and nuclear targeting of viral DNA. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[16] A. Wlodawer,et al. [14]Subsite preferences of retroviral proteinases , 1994 .
[17] T. Copeland,et al. In situ processing of a retroviral nucleocapsid protein by the viral proteinase. , 1991, Protein engineering.
[18] D. Trono,et al. HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator , 1995, Cell.
[19] A. Berger,et al. On the size of the active site in proteases. I. Papain. , 1967, Biochemical and biophysical research communications.
[20] R. Shoeman,et al. Human immunodeficiency virus type 1 protease cleaves the intermediate filament proteins vimentin, desmin, and glial fibrillary acidic protein. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[21] V. Vogt,et al. Analysis of Rous sarcoma virus Gag protein by mass spectrometry indicates trimming by host exopeptidase , 1996, Journal of virology.
[22] G. Yu,et al. Phosphorylation of HIV-1 gag proteins by protein kinase C. , 1993, The Journal of biological chemistry.
[23] H. Demuth,et al. Substrates containing phosphorylated residues adjacent to proline decrease the cleavage by proline-specific peptidases. , 1996, Biochimica et biophysica acta.
[24] J. Louis,et al. Autoprocessing of the HIV-1 protease using purified wild-type and mutated fusion proteins expressed at high levels in Escherichia coli. , 1991, European journal of biochemistry.
[25] S. Tsuyama,et al. Numerous phosphates of microtubule-associated protein 2 in living rat brain. , 1987, The Journal of biological chemistry.
[26] V. Kostka,et al. Specificity studies on retroviral proteinase from myeloblastosis-associated virus. , 1991, Biochemistry.
[27] V. Kostka,et al. Hydrolysis of synthetic chromogenic substrates by HIV-1 and HIV-2 proteinases. , 1990, Biochemical and biophysical research communications.
[28] I. Weber,et al. Molecular dynamics simulations of HIV-1 protease with peptide substrate. , 1994, Protein engineering.
[29] D. Baltimore,et al. Standardized and simplified nomenclature for proteins common to all retroviruses , 1988, Journal of virology.
[30] B. Guy,et al. HIV F/3' orf encodes a phosphorylated GTP-binding protein resembling an oncogene product , 1987, Nature.
[31] T. Copeland,et al. Comparison of the HIV‐1 and HIV‐2 proteinases using oligopeptide substrates representing cleavage sites in Gag and Gag‐Pol polyproteins , 1991, FEBS letters.
[32] M. Bukrinsky,et al. Anti-idiotypic antibody to the V3 domain of gp120 binds to vimentin: a possible role of intermediate filaments in the early steps of HIV-1 infection cycle. , 1996, Viral immunology.
[33] S. Shaltiel,et al. Phosphorylation of vitronectin on Ser362 by protein kinase C attenuates its cleavage by plasmin. , 1997, European journal of biochemistry.
[34] J. Louis,et al. Kinetic and modeling studies of S3-S3' subsites of HIV proteinases. , 1992, Biochemistry.
[35] J. Tözsér,et al. Comparison of the specificity of homo- and heterodimeric linked HIV-1 and HIV-2 proteinase dimers. , 1998, Protein engineering.
[36] A Wlodawer,et al. X-ray crystallographic structure of a complex between a synthetic protease of human immunodeficiency virus 1 and a substrate-based hydroxyethylamine inhibitor. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[37] D. Grobelny,et al. Selective phosphinate transition-state analogue inhibitors of the protease of human immunodeficiency virus. , 1990, Biochemical and biophysical research communications.
[38] M. Inagaki,et al. Site-specific phosphorylation induces disassembly of vimentin filaments in vitro , 1987, Nature.
[39] F. Jensen,et al. Association of ERK2 mitogen-activated protein kinase with human immunodeficiency virus particles , 1997, Journal of virology.
[40] I. Weber,et al. Comparative Studies on the Substrate Specificity of Avian Myeloblastosis Virus Proteinase and Lentiviral Proteinases (*) , 1996, The Journal of Biological Chemistry.
[41] P. Tompa,et al. Mutual protection of microtubule‐associated protein 2 (MAP2) and cyclic AMP‐dependent protein kinase II against μ‐calpain , 1996, Journal of neuroscience research.
[42] T. Copeland,et al. Biochemical and immunological analysis of human immunodeficiency virus gag gene products p17 and p24 , 1988, Journal of virology.
[43] I. Weber,et al. Studies on the role of the S4 substrate binding site of HIV proteinases , 1991, FEBS letters.